## ||Page| |---|---| |Report ofthe Trustees|1-7| |Report ofthe Independent
Auditors|8-10| |Statement of Financial Activities|| |Balance Sheet|| |Cash Flow Statement|13| |Notes to Cash Flow Statement|| |Notes to the Financial Statements|15-25| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ||||||||31 March|2023|31 March|2022| |---|---|---|---|---|---|---|---|---|---|---| ||||||Unrestricted|Restricted|Total funds||1otal funds|| ||||||Funds|Funds||||| |||||Note|6'000|6'000|6'000||6'000|| |INCOMING RESOURCES||||||||||| |Incoming resources from|generated||funds|||||||| |Voluntary
income|||||3,484|402||3,886||2,027| |Activities for generating
funds|||||1,337|169||1,506||1,192| |Investment
income|||||49|||49||34| |Total Incoming resources|||||4,870|571||5,441||3,253| |RESOURCES EXPENDED||||||||||| |Cost ofgenerating
funds:||||||||||| |Costs ofgenerating
voluntary||income|||(954)|||(964)||(845)| |Charitable
Activities||||||||||| |Patients welfare|||||(107)|(180)||(287)||(81)| |Staffwelfare|||||(52)|||(62)||(49)| |Research|||||(2,431)|(125)|(2,556)|||(154)| |Other|||||(64)|||(64)||(128)| |Governance costs|||||(19)|||(19)||(19)| |Investment
management|charges||||(10)|||(10)||(10)| |Total Resources Expended|||||(3,637)|(305)|(3,942)||(1,285)|| |NET INCOMINGI (OUTGOING) RESOURCES|||||1,233|266|1,499||1,968|| |Other recognised
gainsl (losses)||||||||||| |Gams/ (losses) on investment||assets|||(78)|||(78)||58| |Net movement
in funds|||||1,155|266|1,421||2,026|| |RECONCILIATION
OF FUNDS||||||||||| |Total funds
brought
forward|||||3,161|222|3,383||1 356|| |TOTAL FUNDS CARRIED|FORWARD||||4,316||4,804||3,383|| |The Clatterbnd
eCancer Chari|||||||| |---|---|---|---|---|---|---|---| |Balance Sheet|||||||| |At March 2023|||||||| |||||31 March|2023|31 March|2022| |||Unrestriicted|Restricted|Totalfunds||Totalfunds|| |||Fuitds|Funds||||| ||Note|F.'000|F.'000|5'000||7'000|| |FIXEDASSETS|||||||| |Investments|10|1,328|||1,328||1,413| |CURRENT ASSETS|||||||| |Debtors||83|||83||82| |Cash at bank||3,069|||3,557||2,088| |||3,152|488||3,640||2,170| |CREDITORS|||||||| |Amounts
falling due within one year|12|(164)|||(164)||(201)| |NET CURRENT ASSETS/ (LIABILITIES)||2,988|488||3,476||1,970| |TOTAL ASSETS LESSCURRENT LIABILITIES||4,316|488||4,804||3,383| |NET ASSETS||4,316|||4,804||3,383| |FUNDS|13||||||| |Unreshicted
funds|||||4,316||3,161| |Restricted funds|||||488||222| |TOTAL FUNDS|||||4,804||3,383| ## ||||||31 March 2023|31 March 2022| |---|---|---|---|---|---|---| ||||||Total funds|Total funds| ||||||000|F'000| |Net cash (outflow)/inflow||from operating||activities|1,441|(1,202)| |Returns
on investments||and servicing of||finance|17|| |Capital expenditure|and|financial|investment|||| |(Decrease)/increase|ln cash in the||period||1,469|(1,196)| |Reconciliation
of|net cash|flow to movement|in net debt||| |---|---|---|---|---|---| |(Decrease)/increase|in cash|in the period||1,469|(1,196)| |Change
in net debt|resulting|from cash flows||1,469|(1,198)| |Movement
in net debt in the period||||1,469|(1,196)| |Net debt at 1 April||||2,088|3,284| |Net debt at 31 March||||3,557|2,088| ## ## ## |||||||31 March|2023|31 March|2022| |---|---|---|---|---|---|---|---|---|---| |||||||F.'000||E000|| |Net outgoing
resources|||||||1,499||1,967| |Interest received|||||||(15)||| |Online fees and bank|charges||||||22||24| |Investment
fees|||||||10||10| |Dividends
received|||||||(34)||(34)| |Realised
gains/ (losses) on|||sale ofinvestments||||(4)||4| |Decrease/(increase)|in debtors||||||(I)||(71)| |(Decrease)/increase|in creditors||||||(37)|(3,102)|| |Net cash (oufflow)/inflow|||from operating||activities||1,441|(1,202)|| |ANALYSIS OF CASH FLOWS FOR HEADINGS NETTED IN THE|||||||||| |CASHFLOW STATEMENT|||||||||| |||||||31 March|2023|31 March|2022| |||||||E000||E000|| |Returns on investments||and servicing of|||finance||||| |Interest received|||||||15||| |Online fees and bank|charges||||||(22)||(24)| |Investment
fees|||||||(10)||(10)| |Dividends
received|||||||34||34| |Net cash inflow for|returns on investments||||||17||| |and servicing offinance|||||||||| |Capital expenditure|and|financial||investment|||||| |Purchase offixed asset investments|||||||(258)||(170)| |Sale offixed asset investments|||||||269||175| |Net cash (outgow)/intlow|||for capital expenditure||||||| |and financial
investment|||||||||| |ANALYSIS OF CHANGES|||IN NET FUNDS||||||| ||||||At 1 April|Cashflow||At 31 March|| ||||||2022|||2023|| ||||||5'000|6'000||E000|| |Net cash|||||||||| |Cash at Bank|||||2,088||1,469|3,557|| |Total|||||2,088||1,469|3,557|| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## |VOLUNTARY INCOME|||||||| |---|---|---|---|---|---|---|---| ||||31|March|2023|31 March|2022| ||Unrestricted|Restricted||Total||Total|| ||Funds|Funds||Fulids||Funds|| ||Lnooo|6'000||Ln000||DOOO|| |Donations|2,535|402||2,937|||709| |Legacies|949||||949|1,318|| |Total|3,484|402||3,886||2,027|| ## ## ## ## |||||31 March|2023|31 March|2022| |---|---|---|---|---|---|---|---| |||Unrestricted|Restricted|Total||Total|| |||Funds|Funds|Funds||Funds|| |||Ln000|5'000|6'000||EOOO|| |Fundraising|costs|932|||932||821| |Online fees|and bank charges|22|||22||24| |Total||954|||954||845| ## ## ## |CHARITABLE ACTIVITIES CO|STS|||||| |---|---|---|---|---|---|---| ||||31 March|2023|31 March|2022| ||Unrestricted|Restricted|Total||Total|| ||Funds|Funds|Funds||Fuiirls|| ||5'000|5'000|6'000||6'000|| |Patient welfare|107|180||287||81| |Staff welfare|52|||52||49| |Research|2,431|125||2,556||154| |Other|64|||64||138| |Total|2,654|305||2,959||422| ## ## ## ## ## ## ## |STAFF COSTS||| |---|---|---| ||31 March 2023|31 March 2022| ||E000|E'000| |Salaries and Wages|563|486| |Social Security Costs|60|50| |Other Pension Costs|76|65| |Total|699|601| ## |Fixed Asse|t Investments|||||| |---|---|---|---|---|---|---| |||||||Listed| |||||||investments| |||||||F.'000| |MARKET VALUE||||||| |At 1 April 2022||||||1,413| |Additions||||||258| |Disposals||||||(269)| |Revaluations||||||(74)| |At 31 March|2023|||||1,328| |NET BOOK VALUE||||||| |At 31 March|2023|||||1,328| |At 31 March|2022|||||1,413| |||||31 March|2023|31 March 2022| |||||6'000||E'000| |Historical cost at 31 March|||||1,050|972| |There were|no investment|assets outside the UK.||||| |The market|value at 31March:|||||| |||||31 March|2023|31 March 2022| |||||5'000||E'000| |Investment|listed on Stock|Exchange|||1,311|1,387| |Cash held as part ofthe Investment|||Porffolio||17|26| ||||||1328|1,413| ## ## |||||||31 March|2023|31 March 2022|31 March 2022| |---|---|---|---|---|---|---|---|---|---| |||||||8'000||5'000|| |Estele income/gift||aid|||||1||| |Dividendshnterest|||||||6||| |Other|||||||76||| |Total|||||||83||82| |CREDITORS:|AMOUNTS FALLING DUE WITHIN ONE YEAR||||||||| |||||||31 March 2023||31 March 2022|| |||||||P000||B000|| |Other Creditors|||||||164||201| |MOVEMENT|IN FUNDS||||||||| |||||||Net|||| ||||||At 1 April|movement|in|At 31 March|| ||||||2022|funds||2023|| ||||||5'000|M000||5'000|| |Unrestricted|funds||||||||| |General fund|||||3,161||1,155||4,316| |Restriicted funds|||||||||| |Restricted funds|||||222||266||| |TOTALFUNDS|||||3,383||1,421||4,804| |Net movement|in|funds,|included|in the above are as follows:|||||| |||||Incoming|Resources|Gains and||Movement|in| |||||resources|expended|losses||funds|| |||||8'000|5'000|5'000||5'000|| |Unrestricted|funds||||||||| |General fund||||4,870|(3,637)||(78)||1,155| |Restriicted funds|||||||||| |Ro tl1ctod fund"||||671|(aoe)||||266| |TOTALFUNDS|||||||||1,421| ## ## ## |2022 fund asset|a|nd liabilities||||||| |---|---|---|---|---|---|---|---|---| ||||Unrestricted|||Restricted|Total|| |||||fuiids||funds|funds|| |||||E000||E000|E000|| |Fixed assets|||||1,413|||1,413| |Current assets|||||1,948|222||2,170| |Creditors|||||(201)|||(201)| |Total|||||3,160|222||3,382| |Restricted funds||||||||| |The restricted
funds||have ansen as they are donations|||which the donor has specified the income||MUST be used|| |for a particular
purpose.||||||||| |||||||31 March 2023|31 March|2022| |Macmillan
Nurses|based at CCC|||||9,075||9,075| |Gifts for Children||||||1,351||1,351| |Thermoplastics||||||6,250||6,250| |Wigs/Scalp
Coolers||||||1,500||1,500| |)Nork in South pod|Area|||||1,000||1,000| |Restnct Social Purposes||||||383||| |Pancreatic Cancer||Research||||5,075||5,075| |Mattresses||||||4,400||11,500| |TCC - Chemo Chair||||||5,000||5,000| |Bluebell Study||||||6,000||6,000| |Dementia
Clocks||||||460||460| |Sefton Residents
Only||||||359||359| |Aria Programme||||||||6,350| |pre-bereavement|support|||||10,426||10,426| |Research||||||||70,000| |COVID 19Staff and||patients||||||87,868| |Professor Christian||Ottensmeier's|Immunotherapy|Protect||15,000||| |Blood Cancer Team||||||300||| |Massage Guns and||Scalp Coolers||||20,000||| |Chemo
Unit CCCW||||||402,000||| |Total Restricted Funds||||||488,578||222,214| ||||||(D||CQ
Cl||~O|V!|Cl|I|ol|(0|CI|I|I|00
((I|(0|0! m'
N'
(tl|0! m'
N'
(tl|((I|(0||(0|to||(ti|'|I(O
I|| |---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---| ||||||QlO.
SI(||C
0
Gl|O
Ct
4j|(t(||||||||||||||||||||||| ||||||(D||||||||||||||||||||||||||| ||||||0||||||||||||||||||||||||||| ||||||CL|2',|||||||||||||||||||||||||| ||||||6!|6!|||||||||||||||||||||||||| ||||||Vl
Ql
CD
C
m
m
C|0
0l
-C
0
(D
O.0|(tl
0
(0|(0
(O(0|Gl
(tl|||Vd|I||||(D|'|Gl||||||ln
(tl|t|I
Cl|'|I
ln|(4
00
(D|(O
00| ||||||m||||||||||||||||||||||||||| ||||||(0
C
Gl0|n-
S|||||||||||||||||||||||||| ||||||0E
0|0
V
Vl|||||||||||||||||||||||||| ||||||M|C|||||||||||||||||||||||||| |||||||||||||||||||||||||LL|||||||| |m0
S0C
Gl0
(D
'g|Vl
CS
E
(O
(60
6!
C
LL|P!
Cd
CI
0
(6
V!0
Ql'0
C
UI|'D
Gl
C
C00
(OO
R
I
LU
LU
)
0|(0
'0S
0
N
4l|6! S
C0
O.
0
m0
m 0
M0l
Ql
m 0
Ol
Vl
Gl
Vl
(D
Ql
td
Vl
4l
C
Vl
S(0»
0
m6I
0 S
CLS 0C0
(6
(0
Vl
C
C
E—
'0
(0
Gl
C
6!
Vl
ID
dl
m
Ql
Vl I-
'0
m
Ol LL
Vl S
S
(0
Gl
Vl
0
I—00||||LL
(OZZ000
S
13
0
S0
2S
(D
0
0|C
(D
E
GlO.
Ql
Cl
ol
C
Ol
G!
Z-E
Z 0
0
(0
00 ol
Gl
CI 'O
Ql S
0
CL .
vl 3
S0
C
2 E
dl
S
0SS
0 '0
(l. '
0
Vl
O.
0 0||(0S
N
C
'O
Ql
'g
0
CL
S
Vl
0
(6
0
m
CL
(0
S
0
2
S
M
E
(D
m
C
0
(1.
O.
Vl
0|'0
Gl
0
O
C
O
ID
'g5
0
O.
S
Vl
0C
Gl
0Y
6!
CL
Vl
S
0
2
S
Vl
c
dl
Gl
CL
C
0
(l.
O.
Vl
0|IDSE
(US0
13
Gl
a
(O
3
YS
Y
0
O.
vl
0l
0
6!
0
Gl
0
C
6!
E
0
O.
0-
(0
0|IL
(O
z
0
O0
c
LE
3
0
(US
(0
(D
6!
ID0
2
(D
Vl
06!
E
(6
0
0
CL
O.
N
0|LL
(OZZ000
Z
Ql0
m0
Gl0
Ol000I0
0
m
~
O
(6
o
Gl
Gl
(0
ID
S
m
0
0
n.
o.
(0
0|Z
Z
0
0
'0
Ql'g
0
3
N
GlO
2
Vl
S
C
Y
0
cl
n.
N
0|LL
COZZ000
3
hO (L
(6
CO
0Z!
Vl
m O (O
SOZ
CO 0 Z
» C
m
0
P 0
0
Ol .
C
m 5
m
Gl
(0
ID
S CLS
Vl C
Vl
S
S
0I
0.0
O
C '0 C
(U
(0
(6
O
O' O
Y0 0 0
CL O.
CL
CL
CL
(0
Vl
(0
0 0 0
I—I—I-|||LL
(O
Z ~
0 (O
QZ
CE 00
3 O
S LE
0c 3
0 -c0
C
'm
Qml
(0S
m 0C
o
m
Vl
m S0
c- 2
O
Ql
(O
ID
S
(6
Gl
So .0
C 0
(U
(0
O
CL'
0 0
O. O.
CL
CL
N
(0
0 0||(OZZ000
3
CL
tU
ID
C0
CL
Gl
0
GlO.
(O
Z
M
0
CC
0 ~
0»
m
Vl(0
Ql
O
Y 2
E
CO
n»
(0
CL
S 6!
O
2c
(D
M
Ql
m
0 0O.
CL
CL
N
Vl
0 0||I-
LL
CO
Z
Z
0
0
0
'0
Gl
'g
0
(0
S
0
2
dl
Vl
(D
0
0|I—
LL
CO
Z
Z
0
0
0
ID
5
0
CL
Vl
S
0
2
(D
M
(D
0
0|ID
Gl0
(D0
(U0
Ol
E
(0
(U
(L
LO
Z
Z
0
0
0
VD
Gl
10
0
Vl
ID
0
2
Gl
M
Gl
0
n.
O.
(0
0|LL
(O
Z
Z
0
0
0
VD
(D
0
(1
Vl
Ql
0
2
S
Vi
(D
0
(L
(1,
(0
0|LL
0|N
C
(D
E
(0S
C:
C0
(0
M0
(0C
6!0
11S
Vl
m
ID|(0'0
C
Ll0
(D0
Ndl
C:
Gl0| |S
6!0
ID|ID
0
(0S0Z|6!
ID
S
0|||||||(O
Cl|Ct
I|Cd
(0
I|(0
(0
I|Cl
I|Cd
I|I
I|Cl
(tl
I|(tl
Cd
I|M
(ti
I|(A
(t(
I|(D
((!
I|O
N
I|V!
N'
I|I
N'
I|(0
N
I|tn||tn
tn|(0
(O
»|01
(O
I
tent||| |||||8||||||||||||||||||||||||| |---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---| ||||||Gl|||||||||||||||||||||||| |||||Ot
N0
I-
(U|Ql
C
In
Ql
u
6!
O|||(4
N
QtN|p|0
(p|tlt
I|na|(0
Gt||||||(OTZ
dl||ta
tll
E|||||||| ||||||N
ID||||||||||||||Qlu||L8|||||||| ||||||ift||||||||||||||||L'|||||||| |||||O
4l
ul
0
Ia|ID
08
LI
0
al
O|at|th
0
Nal
ID
'O
4l|(4
CI
(4C
0
tll|0
0p
IU|I
Cl|ID
Qd
N|IO|IO
IO
IO
(4|p|p||||0
IU
L'
Gl
QJ
Ql
Ol
'0
ta
QJ||tn
IU
Cl
Gl
E
ID||0
0
m
O.8
QJ C
Ql
p|||||| |||||(I
2|8
8|O|t(
4l||||||||||||Cl||0||I—
Ql
Ol~|||||| |(4
QJ
Ql0
alu
4l
13
4t
(4
QJ|tft2
dlE
ID
(0
Gl0
(0
IL
ID
0
Vt|NpN
0
'0
Ql't!
UJ
Gl
Ql
ID|0
QJ
UJ
(U
Ql
UJ
UJK|10th 00
m
In
Ifl 0
2' 0—
0 0
8
6!
g
Gl
tn
L —8
8
Ql
al
L
0 C0
08
ul
dl
Gl
4!0
8 p. at
n
ut
Vl
8
I- 0
Gl
Cl
Gl
Ol
ln
L 8
N2 (413
I-
tn
In
4!
—QO
0. L
8 p
Ql
'I\
8
O
0
(o alz
Z
L
z 0
mo
8
N
c
In 0
0
I
tlt
0C
IU
QJ 8 8
Ql
z!y
al
m 0
—C 8
m
O 8 8
C
C
Ql
Ol
I-
UJ|||(4
0
h.(t.
al
0
ul
L0
Gl
C
0
D
(0zZ
Ql
0
Ol
C
10
Ql
10
0
O.
N8
ta
QJ
Ql0Lta
QJ
Ql
Ol
tau|||OlE
'O
O
g
Vl
0
ut
O
Qn
C
at
C
U.
O
u|n!
4l
Q
N
C
Qt
m
0-
p
IflC0
JCU
O
u|m
4
(00
Ih
C
0
0
C
0
u|ID
E(t.08
dl
CJ
'tl0
m
m
dl
fh
tn
0
8
L
0
Cl
C
0
QJ|ul
Ql
IO
ID
U!
dl
0
0
Ih
0
JU
C
0
QJ|Gl
a
QJ
0
8
0
Cl
C
0
QJ|Vl
th0
QJ
Ih
C
GlC
4l
0 0
0
N
UR||ta0|0
tt
Ql
0
Ifl
tll
4l
E
8
IU
4l
n
'6!
Gl
Vl
Gl
00
tll
z
3'0
Ql
0
(D
40
Gt
Ntl
Cl
IO
0
QlL
8
Ql
(C|N
C
0
tll
C
0
IL|ln
dl
(4
dl
Vl
dl
6ILI
0
ta
Vl
tnL'
Gl
E
Ql
Ql
0
ul
dl
Cl
E
Ql
E
0
Vl
Ql
tfl
Ql
0
ID
0C
ta8
OlL
(U|Vl
L0
Gla
0
IL
(p
Z
ID
dl
QJ
dl0
ta
Qt
tDttl
10
8
al
O
dl
Vl00
Jt
Gl
VlL
Gl|m
Oo
m
L
m
Cl
Vl
Gl
Vl
00
m c
0
O
dl
Ia
Gl
0 p
L
N
th
0 Z
Ql
tfl Z
Gfa C8
0 QJ
N2 oC
ta
cpQJ
QlOt
O:a
C
0
Cl
(o
mm
Z u
z
4l
8
dt 0
O
ul
6I'0
tll
O
0
O
QlO! Ql
10
ta
«\
8 0
ffl
8 0
0
O
dl
dt|'0
al0
(U
Ol
'0
42
8
6!
O|0
0
C
(0|(4
mo|z
IU
0
QJ|ta
QJ
Ql
0
N
tn60
!Ul
Gf
100
(6
Ql
Ql
dl
E0
'0
Ql
0l
(00
Ql
'O
Gl
Gl
4!
0!8
QJ| ||0z|0||||||||||||||||||||||||||| |Detailed Statement|of|Financial|Financial|Financial|Activities||||| |---|---|---|---|---|---|---|---|---|---| |forthe Year Ended 31 March 2023|||||||||| |||||||31 March|2023|31 March|2022| |||||||Total funds||Total funds|| |||||||f'000||f'000|| |INCOMING
RESOURCES|||||||||| |Voluntary
income|||||||||| |Donations|||||||2,937||709| |Legacies|||||||949||1,318| ||||||||3,886||2,027| |Activities for generating|||funds||||||| |Fundraising
events|||||||1,506||1,192| |Investment
income|||||||||| |Investments|||||||34||34| |Other - Bank interest|||||||15||| ||||||||49||34| |Total incoming
resources|||||||5,441||3,253| |RESOURCES EXPENDED|||||||||| |Costs ofgenerating||voluntary|||income||||| |Fundraising
costs|||||||(932)||(821)| |Onhne fees and bank||charges|||||(22)||(24)| ||||||||(954)||(845)| |Charitable
activities|||||||||| |Patient Welfare|||||||(2&7)||(81)| |Staff Welfare|||||||(52)||(49)| |Research||||||(2,556)|||(154)| |Other|||||||(64)||(128)| |||||||(2,959)|||(412)| |Governance
Costs|||||||||| |Auditors'
remuneration|||||||(9)||(9)| |Strategic management||and||governance|||(10)||(10)| ||||||||(19)||(19)| |Investment
management||||charges|||||| |Charges
payable|||||||(101||(10)| |Total resources expended||||||(3,942)||(1,286)|| |Net expenditure|||||||1,499||1 967|